Potentiation of anticancer drugs: Effects of pentoxifylline on neoplastic cells

International Journal of Molecular Sciences

Volumn 13, Issue 1, 2012, Pages 369-382

  Barancik, Miroslav ^a   Bohacova, Viera ^b   Gibalova, Lenka ^b   Sedlak, Jan ^c   Sulova, Zdena ^b   Breier, Albert ^b  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

^b INSTITUTE OF MOLECULAR PHYSIOLOGY AND GENETICS   (Slovakia)

^c CANCER RESEARCH INSTITUTE   (Slovakia)

Author keywords

Apoptosis; Caspases; Matrix metalloproteinases; Multidrug resistance; P glycoprotein; Pentoxifylline

Indexed keywords

CASPASE 3; CASPASE 9; GELATINASE A; GELATINASE B; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GLYCOPROTEIN P; LIPOCORTIN 5; PENTOXIFYLLINE; PROPIDIUM IODIDE; PROTEIN KINASE B; VINCRISTINE; ANTINEOPLASTIC AGENT; MATRIX METALLOPROTEINASE; MULTIDRUG RESISTANCE PROTEIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CHEMOSENSITIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ENZYME RELEASE; EXPERIMENTAL MODEL; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MULTIDRUG RESISTANCE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; WESTERN BLOTTING; ZYMOGRAPHY; ANIMAL; DRUG EFFECTS; DRUG RESISTANCE; METABOLISM; MOUSE; PHOSPHORYLATION; TOXICITY; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASE 3; CASPASE 9; CELL LINE, TUMOR; DOWN-REGULATION; DRUG RESISTANCE, NEOPLASM; MATRIX METALLOPROTEINASES; MICE; P-GLYCOPROTEIN; PENTOXIFYLLINE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; VINCRISTINE;

EID: 84856297071     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms13010369     Document Type: Article

References (37)

1. Breier, A.; Barancik, M.; Sulova, Z.; Uhrik, B. P-glycoprotein-implications of metabolism of neoplastic cells and cancer therapy. Curr. Cancer Drug Targets 2005, 5, 457-468.
2. Colabufo, N.A.; Berardi, F.; Cantore, M.; Contino, M.; Inglese, C.; Niso, M.; Perrone, R. Perspectives of P-glycoprotein modulating agents in oncology and neurodegenerative diseases: Pharmaceutical, biological, and diagnostic potentials. J. Med. Chem. 2010, 53, 1883-1897.
3. Butanda-Ochoa, A.; Hojer, G.; Morales-Tlalpan, V.; Diaz-Munoz, M. Recognition and activation of ryanodine receptors by purines. Curr. Med. Chem. 2006, 13, 647-657.
4. Duman, D.G.; Ozdemir, F.; Birben, E.; Keskin, O.; Eksioglu-Demiralp, E.; Celikel, C.; Kalayci, O.; Kalayci, C. Effects of pentoxifylline on TNF-alpha production by peripheral blood mononuclear cells in patients with nonalcoholic steatohepatitis. Dig. Dis. Sci. 2007, 52, 2520-2524.
5. Klotz, K.N. Adenosine receptors and their ligands. Naunyn Schmiedebergs Arch. Pharmacol. 2000, 362, 382-391.
6. Miyamoto, K.; Sakai, R.; Kurita, M.; Ohmae, S.; Sanae, F.; Sawanishi, H.; Hasegawa, T.; Takagi, K. Effects of alkyl substituents of xanthine on phosphodiesterase isoenzymes. Biol. Pharm. Bull. 1995, 18, 431-434.
7. Alas, S.; Bonavida, B.; Emmanouilides, C. Potentiation of fludarabine cytotoxicity on non-Hodgkin's lymphoma by pentoxifylline and rituximab. Anticancer Res. 2000, 20, 2961-2966.
8. Rauko, P.; Sedlak, J.; Duraj, J.; Szekeres, M.F.; Novotny, L. Pentoxifylline stimulates drug-induced apoptosis in leukemic cells. Neoplasma 1998, 45, 296-300.
9. Drobna, Z.; Stein, U.; Walther, W.; Barancik, M.; Breier, A. Pentoxifylline influences drug transport activity of P-glycoprotein and decreases mdrl gene expression in multidrug resistant mouse leukemic L1210/VCR cells. Gen. Physiol. Biophys. 2002, 21, 103-109.
10. Stefankova, Z.; Barancik, M.; Breier, A. Overcoming of P-glycoprotein mediated vincristine resistance of L1210/VCR mouse leukemic cells could be induced by pentoxifyline but not by theophylline and caffeine. Neoplasma 1996, 43, 11-15.
11. Gibalova, L.; Sedlak, J.; Labudova, M.; Barancik, M.; Rehakova, A.; Breier, A.; Sulova, Z. Multidrug resistant P-glycoprotein positive L1210/VCR cells are also cross-resistant to cisplatin via a mechanism distinct from P-glycoprotein-mediated drug efflux activity. Gen. Physiol. Biophys. 2009, 28, 391-403.
12. Bravo-Cuellar, A.; Ortiz-Lazareno, P.C.; Lerma-Diaz, J.M.; Dominguez-Rodriguez, J.R.; Jave-Suarez, L.F.; Aguilar-Lemarroy, A.; del Toro-Arreola, S.; de Celis-Carrillo, R.; Sahagun-Flores, J.E.; de Alba-Garcia, J.E.; et al. Sensitization of cervix cancer cells to Adriamycin by Pentoxifylline induces an increase in apoptosis and decrease senescence. Mol. Cancer 2010, 9, 114.
13. Barancik, M.; Bohacova, V.; Sedlak, J.; Sulova, Z.; Breier, A. LY294,002, a specific inhibitor of PI3K/Akt kinase pathway, antagonizes P-glycoprotein-mediated multidrug resistance. Eur. J. Pharm. Sci. 2006, 29, 426-434.
14. Zhang, J.; Ling, Y.; Tang, L.; Luo, B.; Chacko, B.K.; Patel, R.P.; Fallon, M.B. Pentoxifylline attenuation of experimental hepatopulmonary syndrome. J. Appl. Physiol. 2007, 102, 949-955.
15. Dua, P.; Gude, R.P. Antiproliferative and antiproteolytic activity of pentoxifylline in cultures of B16F10 melanoma cells. Cancer Chemother. Pharmacol. 2006, 58, 195-202.
16. Liang, Y.; O'Driscoll, L.; McDonnell, S.; Doolan, P.; Oglesby, I.; Duffy, K.; O'Connor, R.; Clynes, M. Enhanced in vitro invasiveness and drug resistance with altered gene expression patterns in a human lung carcinoma cell line after pulse selection with anticancer drugs. Int. J. Cancer 2004, 111, 484-493.
17. Polekova, L.; Barancik, M.; Mrazova, T.; Pirker, R.; Wallner, J.; Sulova, Z.; Breier, A. Adaptation of mouse leukemia cells L1210 to vincristine. Evidence for expression of P-glycoprotein. Neoplasma 1992, 39, 73-77.
18. Breier, A.; Barancik, M.; Stefankova, Z.; Uhrik, B.; Tribulova, N. Effect of pentoxifylline on P-glycoprotein mediated vincristine resistance of L1210 mouse leukemic cell line. Neoplasma 1994, 41, 297-303.
19. Kupsakova, I.; Rybar, A.; Docolomansky, P.; Drobna, Z.; Stein, U.; Walther, W.; Barancik, M.; Breier, A. Reversal of P-glycoprotein mediated vincristine resistance of L1210/VCR cells by analogues of pentoxifylline. A QSAR study. Eur. J. Pharm. Sci. 2004, 21, 283-293.
20. Chua, B.T.; Gallego-Ortega, D.; de Molina, A.R.; Ullrich, A.; Lacal, J.C.; Downward, J. Regulation of Akt(ser473) phosphorylation by choline kinase in breast carcinoma cells. Mol. Cancer 2009, 8, 131.
21. Viladkar, A.; Chitnis, M. In vitro effects of pentoxifylline and doxorubicin on cell survival and DNA damage in sensitive and MDR-P388 leukemia cells. Cancer Biother. 1994, 9, 143-151.
22. Viladkar, A.; Juvekar, A.; Chitnis, M.; Advani, S. Amelioration of doxorubicin resistance by pentoxifylline in human chronic myeloid leukemia cells in vitro. Sel. Cancer Ther. 1991, 7, 119-126.
23. Fantin, M.; Quintieri, L.; Kusz, E.; Kis, E.; Glavinas, H.; Floreani, M.; Padrini, R.; Duda, E.; Vizler, C. Pentoxifylline and its major oxidative metabolites exhibit different pharmacological properties. Eur. J. Pharmacol. 2006, 535, 301-309.
24. Bu, R.; Uddin, S.; Bavi, P.; Hussain, A.R.; Al-Dayel, F.; Ghourab, S.; Ahmed, M.; Al-Kuraya, K.S. HGF/c-Met pathway has a prominent role in mediating antiapoptotic signals through AKT in epithelial ovarian carcinoma. Lab. Invest. 2010, 91, 124-137.
25. Rishi, L.; Gahlot, S.; Kathania, M.; Majumdar, S. Pentoxifylline induces apoptosis in vitro in cutaneous T cell lymphoma (HuT-78) and enhances FasL mediated killing by upregulating Fas expression. Biochem. Pharmacol. 2009, 77, 30-45.
26. Campos, L.; Oriol, P.; Sabido, O.; Guyotat, D. Simultaneous expression of P-glycoprotein and BCL-2 in acute myeloid leukemia blast cells. Leuk. Lymphoma 1997, 27, 119-125.
27. del Principe, M.I.; del Poeta, G.; Maurillo, L.; Buccisano, F.; Venditti, A.; Tamburini, A.; Bruno, A.; Cox, M.C.; Suppo, G.; Tendas, A.; et al. P-glycoprotein and BCL-2 levels predict outcome in adult acute lymphoblastic leukaemia. Br. J. Haematol. 2003, 121, 730-738.
28. Stamenkovic, I. Matrix metalloproteinases in tumor invasion and metastasis. Semin. Cancer Biol. 2000, 10, 415-433.
29. Song, J.H.; Kim, S.H.; Cho, D.; Lee, I.K.; Kim, H.J.; Kim, T.S. Enhanced invasiveness of drug-resistant acute myeloid leukemia cells through increased expression of matrix metalloproteinase-2. Int. J. Cancer 2009, 125, 1074-1081.
30. Pereda, M.P.; Ledda, M.F.; Goldberg, V.; Chervin, A.; Carrizo, G.; Molina, H.; Muller, A.; Renner, U.; Podhajcer, O.; Arzt, E.; et al. High levels of matrix metalloproteinases regulate proliferation and hormone secretion in pituitary cells. J. Clin. Endocrinol. Metab. 2000, 85, 263-269.
31. Ohsaki, Y.; Ishida, S.; Fujikane, T.; Kikuchi, K. Pentoxifylline potentiates the antitumor effect of cisplatin and etoposide on human lung cancer cell lines. Oncology 1996, 53, 327-333.
32. Magnusson, M.; Hoglund, P.; Johansson, K.; Jonsson, C.; Killander, F.; Malmstrom, P.; Weddig, A.; Kjellen, E. Pentoxifylline and vitamin E treatment for prevention of radiation-induced side-effects in women with breast cancer: A phase two, double-blind, placebo-controlled randomised clinical trial (Ptx-5). Eur. J. Cancer 2009, 45, 2488-2495.
33. Seres, M.; Ditte, P.; Breier, A.; Sulova, Z. Effect of thapsigargin on P-glycoprotein-negative and P-glycoprotein-positive L1210 mouse leukaemia cells. Gen. Physiol. Biophys. 2010, 29, 396-401.
34. Bradford, M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248-254.
35. Peters, W.H.; Fleuren-Jakobs, A.M.; Kamps, K.M.; de Pont, J.J.; Bonting, S.L. Lowry protein determination on membrane preparations: Need for standardization by amino acid analysis. Anal. Biochem. 1982, 124, 349-352.
36. Laemmli, U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227, 680-685.
37. Towbin, H.; Staehelin, T.; Gordon, J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc. Natl. Acad. Sci. USA 1979, 76, 4350-4354.